319 related articles for article (PubMed ID: 23263515)
1. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport.
Cox HD; Rampton J; Eichner D
Anal Bioanal Chem; 2013 Feb; 405(6):1949-58. PubMed ID: 23263515
[TBL] [Abstract][Full Text] [Related]
2. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
Bredehöft M; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
[TBL] [Abstract][Full Text] [Related]
3. Biomarker detection of rhGH doping: an excretion study.
Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
[TBL] [Abstract][Full Text] [Related]
4. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
[TBL] [Abstract][Full Text] [Related]
5. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing.
Tretzel L; Thomas A; Piper T; Hedeland M; Geyer H; Schänzer W; Thevis M
J Pharm Biomed Anal; 2016 May; 123():132-40. PubMed ID: 26896632
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fibronectin 1 in one dried blood spot and in urine after rhGH treatment.
Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
Drug Test Anal; 2017 Jul; 9(7):1011-1016. PubMed ID: 27717280
[TBL] [Abstract][Full Text] [Related]
7. Determination of Recent Growth Hormone Abuse Using a Single Dried Blood Spot.
Reverter-Branchat G; Bosch J; Vall J; Farré M; Papaseit E; Pichini S; Segura J
Clin Chem; 2016 Oct; 62(10):1353-60. PubMed ID: 27507700
[TBL] [Abstract][Full Text] [Related]
8. On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.
Reverter-Branchat G; Segura J; Pozo OJ
Drug Test Anal; 2021 Mar; 13(3):510-522. PubMed ID: 33197153
[TBL] [Abstract][Full Text] [Related]
9. Use of capillary dried blood for quantification of intact IGF-I by LC-HRMS for antidoping analysis.
Mongongu C; Moussa EM; Semence F; Roulland I; Ericsson M; Coudoré F; Marchand A; Buisson C
Bioanalysis; 2020 Jun; 12(11):737-752. PubMed ID: 32479742
[No Abstract] [Full Text] [Related]
10. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
Kniess A; Ziegler E; Thieme D; Müller RK
J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
[TBL] [Abstract][Full Text] [Related]
11. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
12. [Growth hormone and IGF-1 as doping agents in competitive sport].
Jóźków P; Medraś M
Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
[TBL] [Abstract][Full Text] [Related]
13. The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
Guha N; Erotokritou-Mulligan I; Bartlett C; Cowan DA; Bassett EE; Stow M; Sönksen PH; Holt RI
Drug Test Anal; 2012 Jun; 4(6):455-9. PubMed ID: 22511534
[TBL] [Abstract][Full Text] [Related]
14. Genetic and protein biomarkers in blood for the improved detection of GH abuse.
Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
J Pharm Biomed Anal; 2016 Sep; 128():111-118. PubMed ID: 27243825
[TBL] [Abstract][Full Text] [Related]
15. Automated high-throughput analysis of tramadol and O-desmethyltramadol in dried blood spots.
Luginbühl M; Angelova S; Gaugler S; Längin A; Weinmann W
Drug Test Anal; 2020 Aug; 12(8):1126-1134. PubMed ID: 32396691
[TBL] [Abstract][Full Text] [Related]
16. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
17. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS.
Lange T; Thomas A; Walpurgis K; Thevis M
Anal Bioanal Chem; 2020 Jun; 412(15):3765-3777. PubMed ID: 32300840
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
Guha N; Cowan DA; Sönksen PH; Holt RI
Anal Bioanal Chem; 2013 Dec; 405(30):9669-83. PubMed ID: 23934394
[TBL] [Abstract][Full Text] [Related]
19. Potential parameters for the detection of hGH doping.
Kniess A; Ziegler E; Kratzsch J; Thieme D; Müller RK
Anal Bioanal Chem; 2003 Jul; 376(5):696-700. PubMed ID: 12750868
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes.
Höppner S; Delahaut P; Schänzer W; Thevis M
J Pharm Biomed Anal; 2014 Jan; 88():649-59. PubMed ID: 24239904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
